Mohammadi Ali, Mansoori Behzad, Aghapour Mahyar, Baradaran Pooneh Chokhachi, Shajari Neda, Davudian Sadaf, Salehi Shima, Baradaran Behzad
Immunology Research Center, Tabriz University of Medical Sciences, Daneshghah Ave, Tabriz, Iran.
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
J Gastrointest Cancer. 2016 Jun;47(2):187-95. doi: 10.1007/s12029-016-9819-3.
One of the major causes of cancer death internationally and the third most prevalent cancer in the world has been diagnosed with colorectal cancer. Although current routine treatments of cancer have been successful in some extent, mortality caused by adverse effects of these strategies is still raising. Medicinal plants are potential sources of anticancer compounds and can be exploited as a powerful complementary tool. This study aimed to investigate the cytotoxic effects of nettle extract on mouse colorectal cancer cells, HCT.
In the present study, to evaluate the cytotoxicity of nettle extract, MTT assay and trypan blue were performed. Subsequently, DNA fragmentation and TUNEL test was carried out for determination of apoptosis. Real-time PCR test was used to quantify the expression of Caspase-3, Caspase-9, and Bcl-2 which is involved in apoptosis regulation. Finally, cell cycle analysis was conducted by using flow cytometry.
The results of MTT assay showed that the dichloromethane extract of U. dioica extract significantly destroyed cancer cells HCT-116. DNA fragmentation and TUNEL test demonstrated that Utrica extract elicited apoptotic response in the cancer cells. The messenger RNA (mRNA) expression levels of Caspase-3 and Caspase-9 markedly increased, while the Bcl-2 gene was conversely downregulated. Findings of flow cytometry confirmed that cell cycle arrest has occurred at the G2 phase.
Taken together, our experiment showed that subjecting HCT-116 cells to dichloromethane extract of nettle (U. dioica), increases turnover of these cells. Thus, it may be a useful agent in the treatment of colorectal cancer.
结直肠癌已被诊断为国际上癌症死亡的主要原因之一,也是世界上第三大常见癌症。尽管目前癌症的常规治疗在一定程度上取得了成功,但这些治疗策略的副作用导致的死亡率仍在上升。药用植物是抗癌化合物的潜在来源,可作为一种强大的辅助工具加以利用。本研究旨在探讨荨麻提取物对小鼠结肠癌细胞HCT的细胞毒性作用。
在本研究中,为评估荨麻提取物的细胞毒性,进行了MTT试验和台盼蓝试验。随后,进行DNA片段化和TUNEL试验以确定细胞凋亡。使用实时PCR试验定量参与细胞凋亡调节的半胱天冬酶-3、半胱天冬酶-9和Bcl-2的表达。最后,通过流式细胞术进行细胞周期分析。
MTT试验结果表明,异株荨麻的二氯甲烷提取物显著破坏癌细胞HCT-116。DNA片段化和TUNEL试验表明,荨麻提取物在癌细胞中引发了凋亡反应。半胱天冬酶-3和半胱天冬酶-9的信使核糖核酸(mRNA)表达水平显著增加,而Bcl-2基因则相反下调。流式细胞术的结果证实细胞周期停滞在G2期。
综上所述,我们的实验表明,用荨麻(异株荨麻)的二氯甲烷提取物处理HCT-116细胞会增加这些细胞的周转率。因此,它可能是治疗结直肠癌的一种有用药物。